Mutation status of essential thrombocythemia and primary myelofibrosis defines clinical outcome

類似資料

• Recent advances in understanding myelofibrosis and essential thrombocythemia
  著者:: Vainchenker, William, 等
  出版事項: (2016)
• Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project
  著者:: Mora, Barbara, 等
  出版事項: (2018)
• Clinical importance of different calreticulin gene mutation types in wild-type JAK2 essential thrombocythemia and myelofibrosis patients
  著者:: Qiao, Chun, 等
  出版事項: (2014)
• The importance of cytogenetics in polycythemia vera, primary myelofibrosis and essential thrombocythemia
  著者:: Monika Conchon
  出版事項: (2011-12-01)
• The importance of cytogenetics in polycythemia vera, primary myelofibrosis and essential thrombocythemia
  著者:: Conchon, Monika
  出版事項: (2011)